Articles in Scholarly Journals [Incomplete List]

1. Variceal hemorrhage and cystic fibrosis: Outcomes and implications for liver transplantation
   Liver Transplantation, vol. 11, no. 12, pp. 1522–1526, 2005
2. Self-expanding metal stents for the palliation of malignant gastroduodenal obstruction in patients unsuitable for surgical bypass
   Alimentary Pharmacology and Therapeutics, vol. 19, no. 8, pp. 901–905, 2004
3. Use of Fibrin Glue (Beriplast) in the Management of Bleeding Gastric Varices
   Endoscopy, vol. 35, no. 8, pp. 675–678, 2003
4. Emergency colonoscopy for distal intestinal obstruction syndrome in cystic fibrosis patients
   Gut, vol. 51, no. 2, pp. 285–286, 2002
5. Methylene blue staining: Is it really useful in Barrett's esophagus?
   Gastrointestinal Endoscopy, vol. 53, no. 3, pp. 333–335, 2001
6. A prospective single centre study comparing computed tomography pneumocolon against colonoscopy in the detection of colorectal neoplasms
   Gut, vol. 47, no. 6, pp. 832–837, 2000
7. Splanchnic and systemic haemodynamic response to volume changes in patients with cirrhosis and portal hypertension
   Clinical Science, vol. 96, no. 5, p. 475, 1999
8. Randomised study of endoscopic biliary endoprosthesis versus duct clearance for bileduct stones in high-risk patients
   The Lancet, vol. 348, no. 9030, pp. 791–793, 1996
9. Prognostic value of portal haemodynamics
   The Lancet, vol. 346, no. 8982, pp. 1046–1047, 1995
10. An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis
    Journal of Hepatology, vol. 22, no. 5, pp. 513–521, 1995
11. Recent advances in the endoscopic management of variceal bleeding.
    Gut, vol. 36, no. 5, pp. 647–648, 1995
12. Primary amyloidosis and severe intrahepatic cholestatic jaundice.
    Gut, vol. 35, no. 9, pp. 1322–1325, 1994
13. Biliary endoprosthesis and common bile duct stones.
    Gut, vol. 34, no. 4, pp. 574–575, 1993
14. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices
    The Lancet, vol. 342, no. 8868, pp. 391–394, 1993
15. Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis
    Journal of Hepatology, vol. 18, no. 3, pp. 290–294, 1993
16. The management of active variceal bleeding
    Journal of Hepatology, vol. 17, pp. S34–S37, 1993
17. Management of common bile duct stones with a biliary endoprosthesis. Report on 40 cases.
    Gut, vol. 33, no. 10, pp. 1412–1415, 1992
18. Assessment of the percutaneous endoscopic gastrostomy feeding tube as part of an integrated approach to enteral feeding.
    Gut, vol. 33, no. 5, pp. 613–616, 1992
19. Improving biliary-enteric drainage in primary sclerosing cholangitis: experience with endoscopic methods.
    Gut, vol. 32, no. 11, pp. 1364–1368, 1991
20. Portal hypertension--25 years of progress.
    Gut, vol. 32, no. Suppl, pp. S18–S24, 1991
21. Endoscopic sclerotherapy in the management of gastric variceal haemorrhage
    Journal of Hepatology, vol. 13, no. 3, pp. 274–278, 1991
22. A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term magnagement of variceal bleeding
    Hepatology, vol. 11, no. 3, pp. 353–359, 1990
23. Controlled clinical trial of injection sclerotherapy for active variceal bleeding
    Hepatology, vol. 9, no. 2, pp. 274–277, 1989
24. Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices
    Hepatology, vol. 10, no. 3, pp. 279–282, 1989
25. LIVER DISEASE AND BILEDUCT ABNORMALITIES IN ADULTS WITH CYSTIC FIBROSIS
    The Lancet, vol. 334, no. 8677, pp. 1422–1425, 1989
26. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension.
    Gut, vol. 29, no. 3, pp. 372–377, 1988
27. Effect and mechanism of action of isosorbide-5-mononitrate.
    Gut, vol. 29, no. 6, pp. 752–755, 1988
28. A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage
    Hepatology, vol. 6, no. 3, pp. 410–413, 1986
29. Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration
    Hepatology, vol. 6, no. 4, pp. 673–675, 1986
30. Improved survival following injection sclerotherapy for esophageal varices: Final analysis of a controlled trial
    Hepatology, vol. 5, no. 5, pp. 827–830, 1985
31. B1 selective adrenoreceptor blockade for the long term management of variceal bleeding. A prospective randomised trial to compare oral metoprolol with injection sclerotherapy in cirrhosis.
    Gut, vol. 26, no. 4, pp. 421–425, 1985
32. PROPRANOLOL AND CIRRHOSIS
    The Lancet, vol. 326, no. 8447, p. 155, 1985
33. Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension.
    Gut, vol. 25, no. 2, pp. 121–124, 1984
34. Injection sclerotherapy for oesophageal varices: a prospective randomised trial of different treatment schedules.
    Gut, vol. 25, no. 2, pp. 129–132, 1984
35. Injection sclerotherapy for the long-term management of variceal bleeding
    World Journal of Surgery, vol. 8, no. 5, pp. 667–672, 1984
36. Androgen related primary hepatic tumors in non-Fanconi patients
    Cancer, vol. 51, no. 10, pp. 1947–1952, 1983
37. INCREASED LONG-TERM SURVIVAL IN VARICEAL HAEMORRHAGE USING INJECTION SCLEROTHERAPY Results of a Controlled Trial
    The Lancet, vol. 319, no. 8264, pp. 124–127, 1982
38. PROSPECTIVE CONTROLLED TRIAL OF INJECTION SCLEROTHERAPY IN PATIENTS WITH CIRRHOSIS AND RECENT VARICEAL HqMORRHAGE
    The Lancet, vol. 316, no. 8194, pp. 552–554, 1980
39. LIVER DAMAGE FROM LONG-TERM METHYLTESTOSTERONE
    The Lancet, vol. 310, no. 8032, pp. 261–263, 1977
40. Hyperplasia and prolapse of hepatocytes into hepatic veins during longterm methyltestosteronetherapy: possible relationships of these changes to the development of peliosis hepatis and liver tumours
    Histopathology, vol. 1, no. 4, pp. 225–246, 1977